CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.
The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.
sarcoma
Image of the Day: Van Gogh Microscopy
The Scientist and The Scientist Staff | Jan 10, 2018 | 1 min read
Scientists identify the cells that give rise to the soft tissue cancer rhabdomyosarcoma.
Fighting Cancer with Infection, 1891
Catherine Offord | Apr 1, 2016 | 3 min read
Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.